Biomedical Engineering Reference
In-Depth Information
56. Tanino M, Betsuyaku T, Takeyabu K, et al. Increased levels of interleukin-8 in
BAL fluid from smokers susceptible to pulmonary emphysema. Thorax 2002;
57:405-411.
57. Baggiolini M, Dewald B, Moser B. Interleukin-8 and related chemotactic cyto-
kines—CXC and CC chemokines. Adv Immunol 1994; 55:97-179.
58. de Boer WI, Sont JK, van Schadewijk A, Stolk J, van Krieken JH, Hiemstra PS.
Monocyte chemoattractant protein 1, interleukin 8, and chronic airways
inflammation in COPD. J Pathol 2000; 190:619-626.
59. Maus UA, Koay MA, Delbeck T, et al. Role of resident alveolar macrophages
in leukocyte traffic into the alveolar air space of intact mice. Am J Physiol Lung
Cell Mol Physiol 2002; 282:L1245-L1252.
60. Hunninghake GW, Davidson JM, Rennard S, Szapiel S, Gadek JE, Crystal
RG. Elastin fragments attract macrophage precursors to diseased sites in
pulmonary emphysema. Science 1981; 212:925-927.
61. Hubbard RC, Fells G, Gadek J, Pacholok S, Humes J, Crystal RG. Neutrophil
accumulation in the lung in alpha 1-antitrypsin deficiency. Spontaneous release
of leukotriene B4 by alveolar macrophages. J Clin Invest 1991; 88:891-897.
62. Hill AT, Bayley D, Stockley RA. The interrelationship of sputum inflammatory
markers in patients with chronic bronchitis. Am J Respir Crit Care Med 1999;
160:893-898.
63. Stockley RA. Neutrophils and protease
=
antiprotease imbalance. Am J Respir
Crit Care Med 1999; 160:S49-S52.
64. Riise GC, Larsson S, Lofdahl CG, Andersson BA. Circulating cell adhesion
molecules in bronchial lavage and serum in COPD patients with chronic bron-
chitis. Eur Respir J 1994; 7:1673-1677.
65. Sibille Y, Reynolds HY. Macrophages and polymorphonuclear neutrophils in
lung defense and injury. Am Rev Respir Dis 1990; 141:471-501.
66. Hunninghake GW, Crystal RG. Cigarette smoking and lung destruction. Accu-
mulation of neutrophils in the lungs of cigarette smokers. Am Rev Respir Dis
1983; 128:833-838.
67. Atkinson JJ, Senior RM. Matrix metalloproteinase-9 in lung remodeling. Am J
Respir Cell Mol Biol 2003; 28:12-24.
68. Ohnishi K, Takagi M, Kurokawa Y, Satomi S, Konttinen YT. Matrix metallo-
proteinase-mediated extracellular matrix protein degradation in human
pulmonary emphysema. Lab Invest 1998; 78:1077-1087.
69. McCrea KA, Ensor JE, Nall K, Bleecker ER, Hasday JD. Altered cytokine reg-
ulation in the lungs of cigarette smokers. Am J Respir Crit Care Med 1994;
150:696-703.
70. Van den Steen PE, Proost P, Wuyts A, Van Damme J, Opdenakker G. Neutro-
phil gelatinase B potentiates interleukin-8 tenfold by aminoterminal processing,
whereas it degrades CTAP-III, PF-4, and GRO-alpha and leaves RANTES and
MCP-2 intact. Blood 2000; 96:2673-2681.
71. Boots AW, Haenen GR, Bast A. Oxidant metabolism in chronic obstructive
pulmonary disease. Eur Respir J Suppl 2003; 46:14s-27s.
72. MacNee W, Rahman I. Is oxidative stress central to the pathogenesis of chronic
obstructive pulmonary disease? Trends Mol Med 2001; 7:55-62.
